You are here

Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine in Vitro

Title: Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine in Vitro.
Name(s): Robida, John, author
Tang, Hengli, professor directing thesis
Keller, Thomas C. S., III, committee member
Zhu, Fanxiu, committee member
Department of Biological Science, degree granting department
Florida State University, degree granting institution
Type of Resource: text
Genre: Text
Issuance: monographic
Date Issued: 2009
Publisher: Florida State University
Florida State University
Place of Publication: Tallahassee, Florida
Physical Form: computer
online resource
Extent: 1 online resource
Language(s): English
Abstract/Description: The current treatment for hepatitis C virus (HCV) consists of a combination therapy of alpha interferon (IFN-alpha) and ribivirin (RBV). Due to IFN resistance and side effects, new classes of drugs are needed to combat HCV infection. Cyclosporine A (CsA), an immunosuppressive and anti-inflammatory drug, has been shown to suppress HCV via a mechanism independent of the IFN pathway. In order to study the mechanism of CsA action on HCV, CsA resistant strains of HCV subgenomic replicon were selected and characterized. Here we report that different levels of resistance can be seen in different replicons and that different sets of mutations are associated with the different levels of resistance. Several different single cell clones with varying levels of CsA resistance contained mutations in the nonstructural protein 5B (NS5B), the HCV-encoded polymerase. When engineered into wildtype replicon these mutations were sufficient to confer a certain degree of resistance, but not to the original levels of selected replicons. Furthermore, these mutations, both individually and in groups, were able to rescue the lethal phenotype of a point mutation in NS5B (P540A) that has been previously implicated in the blockade of cyclophilins binding. These results demonstrate that CsA exerts selective pressure on the HCV genome despite being known to act on a cellular protein and identify a major target of CsA-mediated inhibition of HCV replication.
Identifier: FSU_migr_etd-1814 (IID)
Submitted Note: A Thesis Submitted to the Department of Biological Science in Partial Fulfillment of the Requirements for the Degree of Master of Science.
Degree Awarded: Fall Semester, 2009.
Date of Defense: August 19, 2009.
Keywords: CsA, Cyclosporine, Hepatitis C Virus, HCV
Bibliography Note: Includes bibliographical references.
Advisory committee: Hengli Tang, Professor Directing Thesis; Thomas C. S. Keller, III, Committee Member; Fanxiu Zhu, Committee Member.
Subject(s): Biochemistry
Molecular biology
Persistent Link to This Record:
Use and Reproduction: This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). The copyright in theses and dissertations completed at Florida State University is held by the students who author them.
Host Institution: FSU

Choose the citation style.
Robida, J. (2009). Characterization of Hepatitis C Virus Subgenomic Replicon Resistance to Cyclosporine in Vitro. Retrieved from